Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-six analysts that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $152.4167. Several e…